{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:34:13Z","timestamp":1764603253817,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal des Maladies Vasculaires"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jmv.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T14:54:43Z","timestamp":1396968883000},"page":"207-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thromboses veineuses \u00e0 r\u00e9p\u00e9tition et syndrome my\u00e9loprolif\u00e9ratif\u00a0: positivit\u00e9 secondaire d\u2019une mutation JAK2\u00a0cinq ans apr\u00e8s l\u2019\u00e9v\u00e9nement initial"],"prefix":"10.1016","volume":"39","author":[{"given":"A.","family":"Salort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Seinturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"L\u00e9v\u00e8que","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pernod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmv.2014.02.005_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1179\/acb.2008.63.2.006","article-title":"Clinical implications of JAK2\u00a0mutations in myeloproliferative disorders","volume":"63","author":"Knoops","year":"2008","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.jmv.2014.02.005_bib0010","first-page":"368","article-title":"Les mutations de JAK2\u00a0dans les syndromes my\u00e9loprolif\u00e9ratifs en 2008","volume":"14","author":"Guerin","year":"2008","journal-title":"Hematologie"},{"issue":"sp\u00e9cial 1","key":"10.1016\/j.jmv.2014.02.005_bib0015","first-page":"55","article-title":"Syndromes my\u00e9loprolif\u00e9ratifs Philadelphie-n\u00e9gatifs","volume":"13","author":"Kiladjian","year":"2007","journal-title":"Hematologie"},{"key":"10.1016\/j.jmv.2014.02.005_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.patbio.2006.06.003","article-title":"JAK2, the JAK2\u00a0V617F mutant and cytokine receptors","volume":"55","author":"Staerk","year":"2007","journal-title":"Pathol Biol (Paris)"},{"issue":"sp\u00e9cial 2","key":"10.1016\/j.jmv.2014.02.005_bib0025","first-page":"47","article-title":"Syndromes my\u00e9loprolif\u00e9ratifs Philadelphie-n\u00e9gatifs","volume":"12","author":"Cassinat","year":"2006","journal-title":"Hematologie"},{"key":"10.1016\/j.jmv.2014.02.005_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008\u00a0World Health Organization criteria and point of care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jmv.2014.02.005_bib0035","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain of function mutation of JAK2\u00a0in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmv.2014.02.005_bib0040","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera but not essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jmv.2014.02.005_bib0045","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK 2\u00a0V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"}],"container-title":["Journal des Maladies Vasculaires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S039804991400050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S039804991400050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:13:45Z","timestamp":1759954425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S039804991400050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S039804991400050X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmv.2014.02.005","relation":{},"ISSN":["0398-0499"],"issn-type":[{"type":"print","value":"0398-0499"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboses veineuses \u00e0 r\u00e9p\u00e9tition et syndrome my\u00e9loprolif\u00e9ratif\u00a0: positivit\u00e9 secondaire d\u2019une mutation JAK2\u00a0cinq ans apr\u00e8s l\u2019\u00e9v\u00e9nement initial","name":"articletitle","label":"Article Title"},{"value":"Journal des Maladies Vasculaires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmv.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}